Epigral Ltd (EPIGRAL) Q4FY26 Management Mirror - Mar-2026 Qtr
Volume and Revenue Outlook
Management introduced a volume growth target of 11% to 15% for FY27 to drive subsequent revenue growth, assuming geopolitical stability. Previously, in the Sep'25 and Dec'25 quarters, management guided for sustained volume recovery and consistently reaffirmed a strategic target to derive 70% of total revenue from derivative and specialty business lines. [Status: Initiated]
4 more themes on the ELITE plan.